e-learning
resources
Paris 2018
Monday, 17.09.2018
Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pneumonia vs non-pneumonia in COPD exacerbations – different risks?
G. Husebø (Bergen, Norway), R. Grønseth (Bergen, Norway), S. Lehmann (Bergen, Norway), B. Lærum (Bergen, Norway), T. Eagan (Bergen, Norway)
Source:
International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Session:
Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Session type:
Poster Discussion
Number:
2277
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Husebø (Bergen, Norway), R. Grønseth (Bergen, Norway), S. Lehmann (Bergen, Norway), B. Lærum (Bergen, Norway), T. Eagan (Bergen, Norway). Pneumonia vs non-pneumonia in COPD exacerbations – different risks?. 2277
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Pneumonia or exacerbation of COPD?
Source: Eur Respir Monogr 2015; 69: 185-196
Year: 2015
Pneumonia risk in COPD patients on long term inhaled corticosteroids – Data from the European COPD audit<%
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013
Distinguishing features of pneumonia and exacerbations in COPD
Source: International Congress 2015 – Prognostic factors in pneumonia: from clinical observations to experimental models
Year: 2015
Pneumonia in exacerbations of COPD: what is the clinical significance?
Source: ERJ Open Res, 6 (1) 00282-2019; 10.1183/23120541.00282-2019
Year: 2020
Impact of bronchiectasis on duration of hospitalization in patients with exacerbations of COPD
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
Risk factors for another hospitalization in COPD patients hospitalized for exacerbation
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
CURB-65 and mortality in pneumonic and non-pneumonic exacerbations of COPD
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011
Predictive factors of 90-days post-discharge COPD acute exacerbation’s recurrence
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016
Survival in COPD patients with hospitalization due to exacerbation
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014
Characterization of readmissions in patients hospitalized with COPD exacerbation
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
COPD and pneumonia
Source: International Congress 2015 – Different data in COPD
Year: 2015
Early readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is associated with high mortality
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Is restricted transfusion approach in the ICU appropriate also for COPD exacerbations?
Source: International Congress 2015 – Acute critical care: news from the ICU
Year: 2015
Rehospitalizations for an acute exacerbation among patients with COPD
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Clinical and demographic factors associated with pneumonia risk in a COPD patient cohort
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015
The impact of bronchiectasis on outcomes in a large cohort of patients hospitalised with exacerbations of COPD
Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients
Year: 2013
Role of comorbidities on mortality in patients hospitalized for COPD exacerbations
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Cardiovascular medications and mortality in patients hospitalised with acute exacerbations of COPD
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
COPD patients admitted in ICU for acute exacerbation: Impact of exacerbation factors on prognosis
Source: International Congress 2016 – Dealing with the complexity of critically-ill patients
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept